CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- 4 Planned sale Chief Executive Officer sold 13,012 shares at an average $61.95 ($806,058)
- 4 Planned sale Chief Executive Officer sold 19,820 shares at an average $63.14 ($1,251,357)
- 4 Planned sale Chief Executive Officer sold 12,791 shares at an average $66.01 ($844,314)
- 4 Planned sale Director sold 1,957 shares at an average $64.63 ($126,490)
- 4 Planned sale Chief Medical Officer sold 14,183 shares at an average $65.45 ($928,326)
- 4 Planned sale Chief Medical Officer sold 9,158 shares at an average $59.64 ($546,153)
- 4 Planned sale Director sold 7,337 shares at an average $58.27 ($427,526)
- 4 Planned sale Director sold 201 shares at an average $51.31 ($10,312)
- 4 Planned sale Chief Medical Officer sold 1,500 shares at $47.41 ($71,115)
- 4 Planned sale Director sold 1,957 shares at an average $49.65 ($97,158)
- 4 Planned sale Chief Medical Officer sold 1,500 shares at $50.59 ($75,885)
- 4 Planned sale Director sold 201 shares at an average $43.44 ($8,731)
- 4 Exercise or conversion Chief Executive Officer acquired 3,000 shares (option exercise)
- 4 Planned sale Director sold 201 shares at an average $46.04 ($9,253)
- 4 Open-market buy Director bought 222,223 shares at $36.00 ($8,000,028)
- 4 Open-market buy Director bought 83,334 shares at $36.00 ($3,000,024)
- 4 Open-market buy Director bought 83,334 shares at $36.00 ($3,000,024)
- 4 Grant or award 10% owner acquired 416,667 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 15 · 283 filings